Wende, S., E. G. Platzer, F. Juhling, J. Pütz, C. Florentz, P. F. Stadler and M. Mörl: Biological evidence for the world's smallest tRNAs. In: Biochimie 100, 151-158 (2014).
doi: 10.1016/j.biochi.2013.07.034
localid: training66678
Bernt, M., A. Donath, F. Jühling, F. Externbrink, C. Florentz, G. Fritzsch, J. Pütz, M. Middendorf and P. F. Stadler: MITOS : improved de novo metazoan mitochondrial genome annotation. In: Molecular Phylogenetics and Evolution 69, 2, 313-319 (2013).
doi: 10.1016/j.ympev.2012.08.023
localid: training64716
Jühling, F., J. Pütz, C. Florentz and P. F. Stadler: Armless mitochondrial tRNAs in enoplea (nematoda). In: RNA Biology 9, 9, 1161-1166 (2012).
doi: 10.4161/rna.21630
localid: training61215
Jühling, F., J. Pütz, M. Bernt, A. Donath, M. Middendorf, C. Florentz and P. F. Stadler: Improved systematic tRNA gene annotation allows new insights into the evolution of mitochondrial tRNA structures and into the mechanisms of mitochondrial genome rearrangements. In: Nucleic Acids Research 40, 7, 2833-2845 (2012).
doi: 10.1093/nar/gkr1131
localid: training58465
Levinger, L., I. Oestreich, C. Florentz and M. Mörl: A pathogenesis-associated mutation in human mitochondrial tRNA Leu(UUR) leads to reduced 3′-end processing and CCA addition. In: Journal of Molecular Biology 337, 3, 535-544 (2004).
Levinger, L., M. Mörl and C. Florentz: Mitochondrial tRNA 3' end metabolism and human disease. In: Nucleic Acids Research 32, 5430-5441 (2004).
Levinger, L., M. Mörl and C. Florentz: Reduced efficiency of 3´end cleavage and CCA addition with mutant human mitochondrial tRNAs could contribute to pathogenesis. In: Biochimica et Biophysica Acta (BBA) - Bioenergetics 1657, Suppl. 1, 54-54 (2004).
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.